CCX appoints Scott Oehrlein Chief Commercial Officer

August 12, 2025

CCX, the market access software leader, announced today that Scott Oehrlein has joined the company's leadership team as Chief Commercial Officer.

Scott has held senior commercial leadership roles at Otsuka, Sanofi, Novartis, Vivus, and Willow BioPharma with responsibility for various markets including US, Canada, Europe, and Latin America. Scott is also an independent board member at Sauvie. Scott is bring this leadership experience to the commercial team at CCX.  

CCX Founder & CEO, Nathan Sigworth said: "As we work to accelerate market acceess through disruptive tech innovation, Scott's experience both in leading major launches and facilitating tech-driven commercial transformation makes him a great addition to the team."

"I am excited to join the CCX team and looking forward to help bring this transformational platform to the global market," said Scott Oehrlein.   

About CCX:
CCX is a software company building and deploying the tech stack for market access: software tools to plan, execute, and administer access agreements between pharma and payers.